Autosomal dominant polycystic kidney disease: modification of disease progression

被引:65
作者
Peters, DJM [1 ]
Breuning, MH [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 AL Leiden, Netherlands
关键词
D O I
10.1016/S0140-6736(01)06531-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease is a common inherited disorder, which is characterised by the formation of fluid-filled cysts in both kidneys that leads to progressive renal failure. Mutations in two genes, PKD1 and PKD2, are associated with the disorder. We describe the various factors that cause variation in disease progression between patients. These include whether the patient has a germline mutation in the PKD1 or in the PKD2 gene, and the nature of the mutation. Detection of mutations in PKD1 is complicated, but the total number identified is rising and will enable genotype-to-phenotype studies. Another factor affecting disease progression is the occurrence of somatic mutations in PKD genes. Furthermore, modifying genes might directly affect the function of polycystins by affecting the rate of somatic mutations or the rate of protein interactions, or they might affect cystogenesis itself or clinical factors associated with disease progression. Finally, environmental factors that speed up or slow down progress towards chronic renal failure have been identified in rodents.
引用
收藏
页码:1439 / 1444
页数:6
相关论文
共 89 条
[71]   An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene [J].
Turco, AE ;
Clementi, M ;
Rossetti, S ;
Tenconi, R ;
Pignatti, PF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) :759-761
[72]   Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice [J].
Upadhya, P ;
Birkenmeier, EH ;
Birkenmeier, CS ;
Barker, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) :217-221
[73]  
van Dijk MA, 1999, J AM SOC NEPHROL, V10, P1916
[74]   The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease [J].
van Dijk, MA ;
Breuning, MH ;
Peters, DJM ;
Chang, PC .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (06) :836-839
[75]  
vanDijk MA, 1995, J AM SOC NEPHROL, V6, P1670
[76]  
Veldhuisen B, 1996, NEPHROL DIAL TRANSPL, V11, P13
[77]   A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2) [J].
Veldhuisen, B ;
Saris, JJ ;
deHaij, S ;
Hayashi, T ;
Reynolds, DM ;
Mochizuki, T ;
Elles, R ;
Fossdal, R ;
Bogdanova, N ;
vanDijk, MA ;
Coto, E ;
Ravine, D ;
Norby, S ;
VerellenDumoulin, C ;
Breuning, MH ;
Somlo, S ;
Peters, DJM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (03) :547-555
[78]   Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney [J].
Ward, CJ ;
Turley, H ;
Ong, ACM ;
Comley, M ;
Biddolph, S ;
Chetty, R ;
Ratcliffe, PJ ;
Gatter, K ;
Harris, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1524-1528
[79]  
WARD CJ, 1994, CELL, V77, P881
[80]   Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease [J].
Watnick, T ;
Phakdeekitcharoen, B ;
Johnson, A ;
Gandolph, M ;
Wang, M ;
Briefel, G ;
Klinger, KW ;
Kimberling, W ;
Gabow, P ;
Germino, GG .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (06) :1561-1571